Skip to main content

Table 1 Comparison between the 2 groups regarding demographic and laboratory findings

From: Vascular endothelial growth factor in relation to the development of hepatocellular carcinoma in hepatitis C virus patients treated by direct-acting antivirals

 

HCV group (n = 25)

HCC group (n = 25)

P value

Gender#

 Male

17 (50)

17 (50)

1.00

 Female

8 (50)

8 (50)

 

Age (years)

58.6 ± 4.4*

59 ± 4.2*

0.74

BMI

20 (19–22)**

24 (22–25)**

< 0.001

Hemoglobin (gm/dl)

13 (11.75–15)**

9.54 ± 1.33*

< 0.001

Platelets (103/Ul)

220 (153.5–240)**

89.8 ± 17.76*

< 0.001

Bilirubin (mg/dl)

0.8 (0.7–0.95)**

2.4 (1.9–3.9)**

< 0.001

Albumin (g/dl)

3.82 ± 0.34*

2.99 ± 0.45*

< 0.001

ALT (U/L)

46 (27.5–65) **

41.72 ± 9.66*

0.15

AST (U/L)

45.28 ± 22.4*

40.88 ± 12.09*

0.39

Creatinine (mg/dl)

1 (0.8–1.03) **

1.3 (1–1.75) **

0.001

AFP (ng/ml)

4.5 (3.2–6.65) **

311.4 ± 209.43*

< 0.001

VEGF (ng/ml)

209.5 ± 137.6*

488.01 ± 194.5*

< 0.001

  1. *Data represented in terms of mean ± SD
  2. **Data represented in terms of median (Q1–Q3)
  3. #Data represented in terms of frequency (percentage), n (%)